
Merck's Dr Dave Maraldo outlines 3 principles for placing manufacturing capacity and how end-to-end ADC supply chains could shift platform thinking.
Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, cost of goods, and sustainability from the start.
over 11 years ago
QRM Tools for Contract Biomanufacturingover 11 years ago
Fill/Finish Trendsover 11 years ago
Biopharma Advances Demand Specialized Expertiseover 11 years ago
Protecting Intellectual Property in Engagements with CMOs


